NEW YORK – A molecular method to identify bacterial infections and detect their antibiotic resistance phenotypes is generalizable to many types of bacteria and can produce results from clinical blood culture samples in about four hours, according to a new study.
The technique, called combined genotypic and phenotypic AST though RNA detection (GoPhAST-R), uses NanoString's enzyme-free hybridization-based technology, and the firm now intends to commercialize the method through an industry partnership.